JPWO2021129655A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021129655A5 JPWO2021129655A5 JP2022539173A JP2022539173A JPWO2021129655A5 JP WO2021129655 A5 JPWO2021129655 A5 JP WO2021129655A5 JP 2022539173 A JP2022539173 A JP 2022539173A JP 2022539173 A JP2022539173 A JP 2022539173A JP WO2021129655 A5 JPWO2021129655 A5 JP WO2021129655A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- fgfr2b
- antibody according
- fgfr1b
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2019127902 | 2019-12-24 | ||
| CNPCT/CN2019/127902 | 2019-12-24 | ||
| PCT/CN2020/138580 WO2021129655A1 (en) | 2019-12-24 | 2020-12-23 | Novel anti-fgfr2b antibodies |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023509402A JP2023509402A (ja) | 2023-03-08 |
| JP2023509402A5 JP2023509402A5 (https=) | 2024-01-05 |
| JPWO2021129655A5 true JPWO2021129655A5 (https=) | 2024-01-05 |
| JP7685999B2 JP7685999B2 (ja) | 2025-05-30 |
Family
ID=76573702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022539173A Active JP7685999B2 (ja) | 2019-12-24 | 2020-12-23 | 新規抗ＦＧＦＲ２ｂ抗体 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230055566A1 (https=) |
| EP (1) | EP4081546A4 (https=) |
| JP (1) | JP7685999B2 (https=) |
| KR (1) | KR20220119471A (https=) |
| CN (1) | CN114901692A (https=) |
| AR (1) | AR120883A1 (https=) |
| AU (1) | AU2020414910A1 (https=) |
| CA (1) | CA3160810A1 (https=) |
| MX (1) | MX2022007959A (https=) |
| TW (1) | TWI864207B (https=) |
| WO (1) | WO2021129655A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230052256A1 (en) * | 2019-12-24 | 2023-02-16 | Dizal (Jiangsu) Pharmaceutical Co., Ltd. | Novel anti-fgfr2b antibodies |
| AU2021366691B2 (en) * | 2020-10-22 | 2024-06-06 | Regeneron Pharmaceuticals, Inc. | Anti-FGFR2 antibodies and methods of use thereof |
| AU2023243773A1 (en) * | 2022-03-28 | 2024-10-24 | Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. | Novel anti-fgfr2 antibodies. |
| KR20250099773A (ko) * | 2022-09-30 | 2025-07-02 | 3에이치 파머슈티컬즈 컴퍼니 리미티드 | 항-fgfr2b 항체 및 이의 용도 |
| AU2023416563A1 (en) * | 2022-12-28 | 2025-07-17 | Suzhou Transcenta Therapeutics Co., Ltd. | Anti-fgfr2b antibody and uses thereof |
| WO2024199362A1 (en) * | 2023-03-31 | 2024-10-03 | Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. | Novel anti-FGFR2 antibodies |
| WO2025067442A1 (zh) * | 2023-09-28 | 2025-04-03 | 南京维立志博生物科技股份有限公司 | 抗fgfr2抗体和包含其的多特异性结合分子 |
| TW202540177A (zh) * | 2023-11-14 | 2025-10-16 | 大陸商蘇州創勝醫藥集團有限公司 | 抗－ＦＧＦＲ２ｂ免疫偶聯物及其於治療癌症的用途 |
| WO2025130860A1 (zh) * | 2023-12-18 | 2025-06-26 | 山东先声生物制药有限公司 | 抗FGFR2b抗体及其应用 |
| WO2025146131A1 (en) * | 2024-01-05 | 2025-07-10 | Beigene, Ltd. | ANTI-FGFR2b ANTIBODIES, CONJUGATES AND METHODS OF USE |
| CN120424212A (zh) * | 2024-01-26 | 2025-08-05 | 上海安领科生物医药有限公司 | 抗FGFR2b抗体及抗体药物偶联物 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005037235A2 (en) | 2003-10-16 | 2005-04-28 | Imclone Systems Incorporated | Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof |
| AU2012351685A1 (en) | 2011-12-14 | 2014-07-03 | Seattle Genetics, Inc. | FGFR antibody drug conjugates (ADCs) and the use thereof |
| US9415118B2 (en) | 2013-03-13 | 2016-08-16 | Novartis Ag | Antibody drug conjugates |
| PH12021552742A1 (en) * | 2013-08-01 | 2022-05-23 | Five Prime Therapeutics Inc | Afucosylated anti-fgfr2iiib antibodies |
| US20170145103A1 (en) * | 2015-11-23 | 2017-05-25 | Five Prime Therapeutics, Inc. | Predicting response to cancer treatment with fgfr2 inhibitors |
| US20180291107A1 (en) * | 2015-11-24 | 2018-10-11 | Eli Lilly And Company | Combination therapy for cancer |
| WO2018095932A1 (en) | 2016-11-22 | 2018-05-31 | Merck Patent Gmbh | Monoclonal antibody directed to fgfr1 |
| WO2018129451A2 (en) * | 2017-01-09 | 2018-07-12 | Merrimack Pharmaceuticals, Inc. | Anti-fgfr antibodies and methods of use |
-
2020
- 2020-12-23 CA CA3160810A patent/CA3160810A1/en active Pending
- 2020-12-23 US US17/788,729 patent/US20230055566A1/en active Pending
- 2020-12-23 AR ARP200103628A patent/AR120883A1/es unknown
- 2020-12-23 CN CN202080089839.0A patent/CN114901692A/zh active Pending
- 2020-12-23 KR KR1020227025530A patent/KR20220119471A/ko active Pending
- 2020-12-23 EP EP20904511.1A patent/EP4081546A4/en active Pending
- 2020-12-23 WO PCT/CN2020/138580 patent/WO2021129655A1/en not_active Ceased
- 2020-12-23 MX MX2022007959A patent/MX2022007959A/es unknown
- 2020-12-23 AU AU2020414910A patent/AU2020414910A1/en active Pending
- 2020-12-23 JP JP2022539173A patent/JP7685999B2/ja active Active
- 2020-12-24 TW TW109145973A patent/TWI864207B/zh active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7519910B2 (ja) | 抗ｍｕｃ１抗体 | |
| RU2737882C2 (ru) | Биспецифические антигенсвязывающие конструкции против her2 | |
| CN115052892A (zh) | 抗ccr8单克隆抗体及其用途 | |
| CN112566662A (zh) | 针对cd47的阻断抗体及其使用方法 | |
| CN110627906A (zh) | 抗pd-l1/4-1bb双特异性抗体及其用途 | |
| JP7820383B2 (ja) | グリピカン－３およびｔ細胞受容体を標的とする免疫グロブリン単一可変ドメインを含むポリペプチド | |
| CN107406497A (zh) | 半胱氨酸连接的纳米抗体二聚体 | |
| CN108290931A (zh) | 对pd-l1具有亲和力的新的多肽 | |
| CA2959671C (en) | Anti-ck8 antibodies for use in the treatment of cancers | |
| JP2003034700A (ja) | ＣＤ４４ｖ６に対する抗体分子 | |
| JPWO2021129655A5 (https=) | ||
| EP2603527A1 (en) | Humanized egfr antibodies | |
| CN119173540A (zh) | 多特异性抗体及其用途 | |
| CN121909212A (zh) | 抗cdh17抗体及其用途 | |
| US20240076406A1 (en) | Single domain antibodies targeting ca-ix as well as compositions comprising same | |
| JPWO2021129672A5 (https=) | ||
| WO2022175474A1 (en) | Vegfa-binding molecules | |
| JP2024020436A (ja) | Ｈｅｒ２標的化剤 | |
| CN116496404A (zh) | 靶向cd47和pd-l1的双特异性抗体及其应用 | |
| JPWO2021129656A5 (https=) | ||
| CN110835372B (zh) | 一种靶向Frizzled7单克隆抗体及其制备方法与应用 | |
| WO2026067461A1 (en) | Multispecific antibody protein and uses thereof | |
| CN120271715A (zh) | 抗体及其药物偶联物和用途 | |
| EP4714976A1 (en) | Anti-fgfr2 antibody and use thereof | |
| WO2025117872A1 (en) | Bispecific antibody-like protein and methods of making and using thereof |